Comparison of clinical effectiveness of treating the abnormal uterine bleeding by using NovaSure and levonorgestrel-releasing intrauterine system

LIU Ping; GUO Lei; MA Xuelian; and FENG Limin

PDF(553 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2016, Vol. 27 ›› Issue (6) : 580-582.

Comparison of clinical effectiveness of treating the abnormal uterine bleeding by using NovaSure and levonorgestrel-releasing intrauterine system

LIU Ping¹, GUO Lei², MA Xuelian², and FENG Limin²

Author information +

History +

Abstract

Objective To investigate the clinical effectiveness of treating the abnormal uterine bleeding by using NovaSure and levonorgestrel-releasing intrauterine system.Methods AUB patients who had been admitted to Tiantan Hospital for NovaSure endometrial ablation and levonorgestrel-releasing intrauterine system between December, 2013 and August, 2014 were retrospectively analyzed. There were 36 patients for NovaSure and 42 patients for levonorgestrel-releasing intrauterine system to compare the information about present and one-year after the operation.Results The scores of NovaSure and LNG-IUS one year after the operation were (324.1±139.7)points and (255.8±96.1)points, respectively (P<0.05).The scores of menalgia were (2.94±1.55) points and (3.73±1.95)points, respectively(P<0.05). The one-year amenorrhea rates were 66.6% and 31.0%, respectively (P<0.05). The rates of relieves of menalgia were 59.1% and 89.2%, respectively (P<0.05).Conclusions NovaSure and LNG-IUS to treat AUB are both significantly effective. It is more effective to treat hypermenorrhea and lead to amenorrhea by NovaSure. It is better to relieve menalgia and the rates of that are higher by LNG-IUS.

Key words

abnormal uterine bleeding / NovaSure / levonorgestrel-releasing intrauterine system (LNG-IUS) / hypermenorrhea / rates of relieving menalgia

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LIU Ping, GUO Lei, MA Xuelian, and FENG Limin. Comparison of clinical effectiveness of treating the abnormal uterine bleeding by using NovaSure and levonorgestrel-releasing intrauterine system[J]. Medical Journal of the Chinese People Armed Police Forces. 2016, 27(6): 580-582

References

[1] Gkrozou F, Dimakopoulos G, Vrekoussis T, et al. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies [J]. Arch Gynaecol Obstet, 2015, 291(6): 1347-1354.
[2] Munro M G, Critchley H O D, Broder M S,et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age [J]. Int J Gynaecol Obstet, 2011 113(1): 3-13.
[3] Fakih M, Cherfan V, Abdallah E,et al. Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population [J]. Int J Gynaecol Obstet, 2011, 113(2): 120-123.
[4] Flegal K M, Carroll M D, Ogden C L,et al. Prevalence and trends in obesity among US adults, 1999-2008[J]. JAMA, 2010, 303(3): 235-241.
[5] Marret H, Fauconnier A, Chabbert-Buffet N,et al. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause [J]. Eur J Obstet Gynecol Reprod Biol, 2010, 152(2): 133-137.
[6] 冯力民, 夏恩兰, 丛捷.应用月经失血图评估月经血量[J]. 中华妇产科杂志, 2001, 36(1): 51.
[7] 冯缵冲,邵敬於. 实用宫腔镜学[M]. 上海:上海医科大学出版社,1999:104.
[8] Hjermstad M J, Fayers P M, Haugen D F,et al. Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review [J]. J Pain Symptom Manage, 2011, 41(6): 1073-1093.
[9] Campbell P, Monaghan C, Parker M,et al. NovaSure endometrial ablation: a review of 400 cases [J]. Gynecol Surg, 2012, 9(1): 73-76.
[10] 边茜, 冯力民, 郭蕾, 等. 诺舒阻抗控制子宫内膜去除术临床观察研究[J]. 中国计划生育和妇产科, 2015, 7(11): 66-70.
[11] 郑杰, 夏恩兰, 孙霞, 等. 宫腔镜子宫内膜切除联合左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J]. 中国妇幼保健, 2012, 27(18): 2849-2852.
[12] Choi Y S, Cho S H, Lim K J, et al. Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis [J]. Growth Factors, 2010, 28(6): 452-460.
[13] Heikinheimo O, Gemzell-Daniellsson K. Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS) [J]. Acta Obstet Gynecol Scand, 2012, 91(1): 3-9.
[14] Bednarek P H, Jensen J T. Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS [J]. Int J Women Health, 2009, 1: 45-58.
[15] 邓姗, 郎景和. 左炔诺孕酮宫内缓释系统的临床功用及相关基础研究[J]. 国外医学: 妇产科学分册, 2005, 31(5): 285-288.